Pain News and Research

Latest Pain News and Research

Leading cancer journals publish OncoGenex's custirsen pre-clinical and Phase II study data

OncoGenex Pharmaceuticals, Inc. announced today that data from two studies, a Phase II clinical study and a pre-clinical study, evaluating the investigational compound custirsen, were published in the September issues of the journals Clinical Cancer Research and Cancer Research.

7 Sep 2011

Oxycodone no safer than codeine for breastfed infants: New study

Doctors have been prescribing codeine for postpartum pain management for many years, and, until recently, it was considered safe to breastfeed while taking the opioid. But the death of an infant exposed to codeine through breast milk has many health care providers questioning the safety of the drug when used by breastfeeding mothers.

7 Sep 2011

New blood test could help identify babies at risk of sickle cell disease

A new blood test is being developed by researchers in Cambridge and Oxford, which, for the first time, could help identify babies at risk of a severe form of sickle cell disease, allowing immediate and more intensive treatment to be given, thanks to a grant from children's charity Action Medical Research.

7 Sep 2011

Duodenal switch may lead to more weight loss but more complications: Study

A less usual and common type of obesity surgery may spur more weight loss than its far more popular cousin, gastric bypass - but at the price of greater long-term risks, researchers reported.

6 Sep 2011

FDA reviews safety issues of bisphosphonates for osteoporosis

An advisory committee for U.S. Food and Drug Administration meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates amid worry that their long-term use could cause rare fractures of the thighbones and affect the jawbone. The committee will evaluate whether women should temporarily stop using the drugs or use them for only a few years.

6 Sep 2011

Robert Gordon University scientists to develop new treatment for cystinosis

A team of researchers at Robert Gordon University has secured a six figure sum from Sparks, a leading children’s medical research charity, to develop a revolutionary treatment for a rare genetic disorder.

6 Sep 2011

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

BioDelivery Sciences International, Inc. announced positive preliminary results from its Phase 1 study assessing the pharmacokinetics of a BEMA Buprenorphine/Naloxone formulation.

6 Sep 2011

Enrollment complete in DURECT's POSIDUR Phase III study for post-surgical pain

DURECT Corporation announced today the dosing of the last patient in the U.S. pivotal Phase III clinical study for POSIDUR known as BESST.

6 Sep 2011

Vertex VX-509 12-week Phase 2a study on RA meets two primary endpoints

Vertex Pharmaceuticals Incorporated today announced that treatment with the investigational selective oral JAK3 inhibitor VX-509 in a Phase 2a trial resulted in substantial and statistically significant improvements in multiple measurements of rheumatoid arthritis (RA) activity.

6 Sep 2011

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that it has entered into agreements with Quintiles Commercial US, Inc. and Integrated Commercialization Services, Inc. (ICS) to support the anticipated launch of EXPAREL, should it be approved by the Food and Drug Administration (FDA) later this year.

6 Sep 2011

The Arthritis Society warns Canadians to check for OA

Canadians who never have their joint pains and aches examined by a doctor could be making the problem much worse, The Arthritis Society warns.

6 Sep 2011

Chondroitin sulfate decreases pain and improves hand function in patients with OA

New research shows that chondroitin sulfate significantly decreased pain and improved hand function in patients with osteoarthritis (OA) of the hand compared with those in the placebo group. Results of the clinical trial available today in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR), also report that chondroitin sulfate improves grip strength and relieves morning stiffness.

6 Sep 2011

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announces oral communication of the Phase II clinical trial results of its orphan product Livatag at the annual congress of ILCA, the only international organization devoted exclusively to liver cancer research with participation of worldwide best specialists.

6 Sep 2011

Berlin to market wide range of Acino Pharma's current and future products in Thailand

Berlin Pharmaceutical Industry Co., Ltd. and Acino Pharma AG signed a long term partnership agreement under which Berlin will market a wide range of the Swiss company's current and future products in Thailand.

5 Sep 2011

Study finds link between long-term dietary patterns and human gut bacteria

"You are what you eat" is familiar enough, but how deep do the implications go? An interdisciplinary group of investigators from the Perelman School of Medicine at the University of Pennsylvania have found an association between long-term dietary patterns and the bacteria of the human gut.

3 Sep 2011

Early treatment of chronic hip pain in young athletes may have long term impact on health

Treating young athletes with chronic hip pain may be the key to slowing or halting the progression of degenerative hip disease.

3 Sep 2011

SWOG selects four cancer researchers for 2011 Young Investigator Training Course

SWOG has selected four talented, early-career researchers for its 2011 Young Investigator Training Course. These four will attend a three-day workshop September 19 - 21 in Seattle, Wash., for intensive training in how to design and conduct cancer clinical trials.

3 Sep 2011

Health care politics: Perry's stem cell controversy, presidential contenders and health law; Biden Medicare fact check

Texas Gov. Rick Perry, who recently underwent an experimental injection of his own adult stem cells to relieve back pain, pushed a bill through the Legislature in June that paves the way for a company co-owned by his doctor to become the first state-approved "bank" to store and cultivate such cells for medical treatment that fact illustrates two aspects of his record that are drawing increasing attention as he pursues the presidency: his enthusiasm for ideas that are sometimes outside the scientific mainstream and what critics view as his willingness to use the levers of state government to benefit friends and political benefactors.

3 Sep 2011

Florida steps up efforts against pill mills; Hospital executives under scrutiny

The New York Times looks at Florida's efforts to stop illegal sales of prescription drugs while other outlets examine local hospital issues.

2 Sep 2011

AAPB publishes first handbook on sport psychology, neurofeedback and biofeedback

The Association for Applied Psychophysiology and Biofeedback (AAPB), an international society for mind-body research, healthcare, and education, recently published the first handbook on sport psychology, neurofeedback, and biofeedback to offer performance techniques for reaching maximum potential.

2 Sep 2011

Pain News and Research

Latest Pain News and Research

Leading cancer journals publish OncoGenex's custirsen pre-clinical and Phase II study data

Oxycodone no safer than codeine for breastfed infants: New study

New blood test could help identify babies at risk of sickle cell disease

Duodenal switch may lead to more weight loss but more complications: Study

FDA reviews safety issues of bisphosphonates for osteoporosis

Robert Gordon University scientists to develop new treatment for cystinosis

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

Enrollment complete in DURECT's POSIDUR Phase III study for post-surgical pain

Vertex VX-509 12-week Phase 2a study on RA meets two primary endpoints

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

The Arthritis Society warns Canadians to check for OA

Chondroitin sulfate decreases pain and improves hand function in patients with OA

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

Berlin to market wide range of Acino Pharma's current and future products in Thailand

Study finds link between long-term dietary patterns and human gut bacteria

Early treatment of chronic hip pain in young athletes may have long term impact on health

SWOG selects four cancer researchers for 2011 Young Investigator Training Course

Health care politics: Perry's stem cell controversy, presidential contenders and health law; Biden Medicare fact check

Florida steps up efforts against pill mills; Hospital executives under scrutiny

AAPB publishes first handbook on sport psychology, neurofeedback and biofeedback

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in